P 300 is critical in cell growth, differentiation, apoptosis, and DNA repair and is closely linked to many human diseases, cancer in particular 1-3 . It functions as a scaffolding protein that recruits numerous nuclear components, including transcription factors, co-activators, and subunits of the RNA polymerase II complex to chromatin 4-6 . p300 possesses an intrinsic histone acetyltransferase (HAT) activity and acetylates histones, directly altering chromatin structure and promoting expression of specific genes 7-9 . This large, ~300 kDa, evolutionarily conserved enzyme is functionally related to and cooperates with paralogous CBP, and both share the same domain architecture consisting of a diverse set of proteinand DNA-binding modules. Along with the N-terminal nuclear receptor interaction domain, a transcriptional adaptor zinc-finger 1 (TAZ1), and a kinase-inducible CREB interaction region (KIX), p300 contains a combination of a bromodomain, a RING finger, and a plant homeodomain (PHD) finger preceding the catalytic HAT domain (Fig. 1a) . The HAT domain is followed by a ZZ-type zinc finger, another TAZ domain (TAZ2), and an interferon-binding domain. Although these domains predominantly associate with activators, basal transcription factors, and components of the multisubunit HAT complexes, some have also been implicated in control of the p300 catalytic activity 10,11 . The HAT domain itself is regulated through its autoinhibitory loop (AIL), which in a hypoacetylated form suppresses the catalytic activity but releases the inhibition on hyperautoacetylation 7,12 . An additional layer of p300 regulation has been suggested based on the recent structure of the p300 region encompassing bromodomain, RING, PHD, and the HAT domain (BRPH), in which the RING finger aids in the inhibition through occluding the HAT active site in conjunction with AIL 13 . Owing to their crucial role in a magnitude of signaling pathways, biological activities of p300 domains have been studied extensively; however, the function of the ZZ domain remains unclear. In this study, we show that the ZZ domain of p300 recognizes histone H3 tail and therefore represents a novel epigenetic reader. Our findings suggest that the histone binding function of ZZ and acetyllysine binding function of bromodomain are essential in chromatin targeting and catalytic activities of p300. Particularly, recognition of histone H3 by the ZZ domain promotes acetylation of primarily histone H3K27 and H3K18 sites.
Results
The ZZ domain of p300 targets histone H3. The histone binding activity of the ZZ domain of p300 (p300-ZZ) was originally identified by peptide pull-down experiments (Fig. 1b,c) . We found that glutathione S-transferase (GST)-tagged p300-ZZ binds to the residues 1-22 of the histone H3 tail but does not recognize other regions of H3 or other histones, and that common single posttranslational modifications (PTMs) on H3 do not affect this interaction ( Fig. 1b,c) . To characterize the binding in detail, we expressed p300-ZZ as an 15 N-labeled protein and tested it in 1 H, 15 N heteronuclear single quantum coherence ( 1 H, 15 N HSQC) experiments ( Fig. 1d ). Gradual addition of the H3 1-12 peptide (residues 1-12 of H3) to the p300-ZZ NMR sample led to large resonance changes. These changes were in the intermediate exchange regime on the NMR timescale and suggested a tight binding. In agreement, an 8.8-μ M binding affinity of p300-ZZ for the H3 1-12 peptide was measured by fluorescence assays (Fig. 1e,f) . Methylation of H3K4, a common target of epigenetic readers, or acetylation of H3K4 had no effect, as almost identical patterns of resonance changes were observed in NMR titration experiments, and the comparable binding affinities were measured for the correspondingly modified peptides ( Fig. 1e and Supplementary Figs. 1a and 2 ). Importantly, the K d value for the p300-ZZ/H3 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] interaction was in the range of binding affinities exhibited by the majority of histone binding modules [14] [15] [16] , corroborating the notion that the ZZ domain of p300 is a new member of the family of epigenetic readers that select for histone H3.
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Molecular mechanism of the p300-ZZ association with H3. To elucidate the molecular basis for the recognition of the H3 tail, we determined a 2.0-Å-resolution crystal structure of the p300-ZZ/ H3 complex using the chimeric construct containing residues 1-6 of H3 linked to the residues 1,663-1,713 of p300 ( Fig. 1g,h) . The 1 H, 15 N HSQC spectra of the linked H3-ZZ construct and of the isolated ZZ domain in the presence of a tenfold excess of H3 1-12 peptide overlaid well, confirming that the linked and unlinked ZZ-H3 complexes adopt identical structures in solution ( Supplementary Fig. 3 ). The structure showed two H3-ZZ molecules forming the complex in which the H3 region of one molecule is bound to the ZZ domain of another molecule (Table 1 and Supplementary Fig. 4a ).
The p300-ZZ fold is stabilized by two zinc-binding clusters, a couple of twisted two-and three-stranded antiparallel β -sheets, and a short α -helix (Fig. 1g ). The histone residues pair with the first β -strand (residues 1,665-1,669 of ZZ), creating the third antiparallel β -stand, and make extensive intermolecular contacts with the domain (Fig. 1g ). Characteristic β -sheet interactions are observed between the backbone amides of Ala1, Thr3, and Gln5 of H3 and T1669, V1667, and R1665 of the ZZ domain. Ala1 occupies a highly negatively charged binding site where the NH 3 + group of Ala1 is anchored through the hydrogen bonds with T1669 and N1671 and a salt bridge with D1690 (Figs. 1g,h and 2a). The guanidinium moiety of Arg2 is restrained via a salt bridge with the carboxyl group of D1688 and hydrogen bonds with the backbone carbonyl oxygen of E1687, whereas the backbone amide of Arg2 is involved in direct and water-mediated hydrogen bonding contacts with D1688. The side chain of Lys4 lays in a groove formed by the aromatic ring of F1666 and the side chain of D1664, the negatively charged carboxylic group of which forms a salt bridge with the ε -amino group of Lys4 ( Figs. 1g and 2b) . The formation of the salt bridge most likely accounts for the indifference of p300-ZZ towards PTMs on H3K4, which would augment cation-π and hydrophobic interactions with F1666 but diminish the electrostatic contact with D1664. The side 15 N HSQC spectra of p300-ZZ collected upon titration with H3 peptide (residues 1-12 of H3). Spectra are color coded according to the protein-to-peptide molar ratio. e, Binding affinities of wild-type p300-ZZ for the indicated histone peptides measured by tryptophan fluorescence. The experiments were carried out in triplicate for H3 and H3K4ac and in duplicate for methylated H3. f, Representative binding curve used to determine the K d values by fluorescence. See also Supplementary Fig. 2 . g, A ribbon diagram of the p300-ZZ domain (light blue) in complex with histone H3 tail (residues 1-6) (orange). h, Electrostatic surface potential of p300-ZZ is colored blue (positive charge) and red (negative charge) with the bound histone H3 tail shown in stick representation. BD, bromodomain; IBiD, interferon-binding domain.
chain of Gln5 is hydrogen bonded to the guanidinium group of R1665. This mechanism for the coordination of H3 is distinctly different and distinguishes the ZZ domain from all currently known readers, including those that bind to the N terminus of H3 ( Supplementary Fig. 4b,c ). The critical role of the Ala1 recognition was substantiated by testing truncated variants of H3 and mutating the binding site residues in p300-ZZ ( Fig. 2 ). Peptide pull-down and NMR experiments with various fragments of histone H3 confirmed that at least the first two residues of H3 are required for the interaction (Fig. 2c,d ,h). The absence of chemical shift changes in 1 H, 15 N HSQC spectra of p300-ZZ upon titration with either the AGSGSG peptide, Ac-RTKacQTARKSTG (H3K4ac 2-12 ), or Ac-H3 3-10 suggested that both the H3 sequence and the presence of the positive charge on Ala1 are necessary for the interaction (Fig. 2h ). Replacement of Ala1 with a larger residue, valine, in H3A1V 1-6 resulted in a reduction in the binding ~threefold, and very small resonance perturbations in p300-ZZ upon addition of H4 1-9 (Ser1) indicated an almost negligible binding. Substitution of the Ala1-binding site residues, N1671 or D1690, with an alanine abolished the interaction of p300-ZZ with H3 peptides or calf thymus histones in pulldown assays ( Fig. 2e and Supplementary Fig. 5 ) and NMR titrations ( Fig. 2c ). Further, mutation of D1688 and F1666 or deletion of the first five (1,663-1,667) residues in p300-ZZ substantially reduced the binding, pointing to the essential role of the Arg2 and Lys4 coordination and formation of the β -sheet, respectively ( Fig. 2e and Supplementary Figs. 1b and 5b).
Recruitment of p300 to chromatin depends on synergistic histone binding functions of ZZ and bromodomain.
The importance of the histone binding activity of the ZZ domain for the association of p300 with chromatin was examined by chromatin immunoprecipitation (ChIP) followed by western blot and salt fractionation assays in H1299 cells stably expressing p300 fragment containing bromodomain-RING-PHD-HAT-ZZ-TAZ2 (BRPHZT) (Fig. 2f,g and Supplementary Fig. 5c-e ). Bromodomain of p300/CBP was previously shown to target acetylated lysine residues in histone and non-histone proteins, and the bromodomain-RING-PHD (BRP) region binds hyperacetylated nucleosomes and acetyllysine-containing peptides 13, [17] [18] [19] [20] [21] [22] [23] . In agreement, our NMR titration experiments confirmed that bromodomain within BRP associates with an acetylated peptide but does not recognize unmodified H3 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , which is the ligand of ZZ ( Supplementary Fig. 6a ). Deletion or loss-offunction mutations of either ZZ (Δ ZZ, N1671A, and D1690A) or bromodomain (Δ BD and N1132A) substantially reduced the association of p300 BRPHZT with chromatin containing acetyllysine marks, and deletion or mutation of both domains had an additive effect ( Fig. 2f ,g and Supplementary Fig. 5c -e). These data indicate that both readers, bromodomain and ZZ, contribute to the interaction of p300 BRPHZT with chromatin although their ligands differ: ZZ binds to the N terminus of H3 independent of PTMs, whereas bromodomain binds to various histone sequences acetylated at lysine residues, favoring poly-acetylated H4 13, 17, 21 . The fact that the impaired histone binding activity of either ZZ or bromodomain led to such a notable decrease in chromatin binding of p300 BRPHZT suggests that the two interactions cooperate in the recruitment or retention of p300 at chromatin. Deletion of AIL appears to have no effect on the association of BRPHZT with chromatin ( Fig. 2g and Supplementary Fig. 5d ).
P300-ZZ and HAT cooperate in binding to H3 tail. Much like the BRP region preceding the HAT domain, the following ZZ domain is in close proximity to the HAT domain with only ~two residues connecting the domains. We found that the isolated ZZ and HAT domains interact only weakly, as the HAT domain caused very small changes in ZZ; however, subsequent titration of H3 1-12 peptide resulted in large resonance perturbations, suggesting that the histone binding function of ZZ is preserved in the presence or absence of HAT ( Fig. 3a) . Analysis of the fluorescence-derived binding curves for the interaction of the natively linked HAT-ZZ construct with H3 1-12 peptide required a two-site binding model, which implies that both HAT and ZZ are engaged with the peptide. The fitting yielded two K d values of 2.6 μ M and 29 μ M, which are comparable to K d s measured for the isolated ZZ and HAT domains (8.8 μ M and 38 μ M, respectively) ( Fig. 3b, c) . The longer H3 peptide (residues 1-31, H3 1-31 ), however, was bound by HAT-ZZ substantially tighter, revealing a cooperative binding and an in cis mechanism ( Fig. 3b-d and Supplementary Fig. 2b ). In support, the cooperativity was no longer observed for binding of the HAT-ZZ N1671A construct that harbors loss-of-function ZZ to the H3 1-31 peptide (Fig. 3b ). The cooperative binding was also eliminated in wild-type HAT-ZZ when the histone H3 5-31 peptide, in which the ZZ-targeted sequence is deleted, was used as ligand. The binding affinities of wild-type HAT-ZZ and HAT-ZZ N1671A for the H3 5-31 peptide (K d = 21 μ M and 17 μ M, respectively) were essentially the same as the binding affinity of the isolated HAT domain for H3 
Interaction of p300-ZZ with H3 directs acetylation of H3K27 and H3K18 in vitro. The BRP region has been shown to associate with the HAT domain with the binding affinity of 1.6 μ M 13 . We confirmed the direct and robust interaction through monitoring rapid disappearance of resonances of the 15 N-labeled BRP region induced by the unlabeled HAT domain in 1 H, 15 N HSQC experiments ( Supplementary Fig. 6 ). However, this interaction was weakened when the linked HAT-ZZ was titrated in, indicating a conformational mobility within the HAT-ZZ construct that may alter the priming of BRP ( Supplementary Fig. 6b ). The dynamic organization of the adjacent to the HAT domain modules may facilitate substrate and acyl-CoA association, enlarge the substrate pool of p300, and mediate its HAT activity. To determine whether the ZZ/H3 interaction affects the catalytic activity of p300, we carried out in vitro HAT assays using the p300-BRPHZ fragment and reconstituted unmodified nucleosomes. We found that wild-type p300-BRPHZ acetylates H3 on H3K27 and H3K18 robustly, but very little acetylation was detected on H3K9 and H3K4 ( Fig. 3e-k and Supplementary Fig. 7a ). Mutation of the ZZ residues critical for binding to H3, N1671 and D1690, to an alanine in p300-BRPHZ substantially reduced the HAT activity on H3K27 and H3K18 but did not affect acetylation on H3K4 and H3K9. Likewise, the deletion of ZZ led to a considerable reduction of acetylation on H3K27 and H3K18; however, it had no effect on acetylation of H3K4 and H3K9 ( Fig. 4a-e ). Furthermore, the HAT activity of p300-BRPHZ on the nucleosome, in which the first two residues of H3 (Ala1-Arg2, that are required for the binding of ZZ) were deleted, was severely compromised ( Fig. 4f,g) . In contrast, mutation of N1132 that impairs acetyllysine binding of bromodomain led to a substantial decrease in acetylation of all lysine residues tested, H3K4, K3K9, H3K18, and H3K27 ( Fig. 3e-k) . These results suggest that the acetyllysine binding function of bromodomain is necessary for the overall catalytic activity of p300-BRPHZ on the nucleosome, whereas the ability of p300-BRPHZ to acetylate primarily H3K27 and H3K18 is due to binding of the ZZ domain to H3. p300 bromodomain was previously proposed to bind acetylated substrates to facilitate acetylation at other sites 13, 19 . Although we used unmodified nucleosomes in the HAT assays, the initial acetylation of histones by p300-BRPHZ can provide a feed-forward mechanism, supporting this idea. Potentially, AIL of the HAT domain can also be a ligand for bromodomain ( Fig. 4h ), as this loop is autoacetylated in endogenous and recombinant p300 12 , and bromodomain of CBP interacts with the AIL peptide acetylated at K1596 19 . Although binding affinities of wild-type p300-BRPHZ, p300-B N1132A RPHZ, and p300-BRPH ΔAIL Z for H3 suggest that abrogating acetyllysine binding of bromodomain or deleting AIL has little effect on the association of p300-BRPHZ with this peptide ( Fig. 5a,b ), comparison of acetylation levels produced by wildtype p300-BRPHZ and p300-BRPH ΔAIL Z in 10 min reveals that the deletion of AIL stimulates the HAT activity of p300-BRPHZ ( Fig. 4a-e ). These data are in agreement with the previous reports on inhibition of the p300 catalytic activity by hypoacetylated AIL 12 . It was proposed that the hypoacetylated AIL might contact a negatively charged patch on the HAT domain surface blocking the active site, whereas acetylation of AIL releases this loop freeing the active site 7, 12 . At least ten lysine residues in AIL can be acetylated 12 ; however, it remains unclear as to how many of these lysines should be acetylated to regulate equilibrium between an inhibitory (less acetylated, more positively charged) state of AIL and an activation (more acetylated, less positively charged) state of AIL. Further studies are required to establish the effect of poly-autoacetylation of AIL on this equilibrium and explore whether bromodomain is capable of targeting it, which would shift the equilibrium towards the AIL activation state facilitating the catalytic activity ( Fig. 4h ).
H3K18 and H3K27 acetylation requires H3-binding activity of p300-ZZ in vivo.
To determine whether the H3-binding by the ZZ domain is required for p300-mediated histone acetylation in cells, we examined acetylation marks in H1299 cells stably expressing Flagtagged wild-type or mutated p300-BRPHZT. As expected, ectopic expression of wild-type p300-BRPHZT increased the global levels of acetylation at all sites tested ( Fig. 5c-f ). In support of our model, p300-BRPHZT mutations that abrogate histone binding of the ZZ domain, N1671A and D1690A, or deletion of ZZ greatly attenuated the increase of H3K18 and H3K27 acetylation without affecting H3K4, H3K9, and H4 acetylation ( Fig. 5c-f ). Similar changes were observed in 293T cells transiently expressing full-length p300 or the ZZ-mutated counterparts ( Supplementary Fig. 7b ). Mutation of N1132 that disrupts acetyllysine binding of bromodo- WT  N1671A  D1690A  N1132A  N1132A+  D1690A  Fluorescence signal   10  20  40  60  80  10  20  40  60  80  10  20  40  60  80  10  20  40  60  80  10 main or deletion of bromodomain led to a reduction of acetylation at all sites; however, acetylation of H4 was most notably impeded ( Fig. 5c-f ). These findings indicate that while acetylation of histones, H4 in particular, by p300 requires the acetyllysine binding activity of p300-bromodomain, specific acetylation of the H3K18 and H3K27 sites 24, 25 requires the H3-binding activity of p300-ZZ.
We next examined the role of the ZZ/H3 interaction in chromatin binding and acetylation function of p300-BRPHZT in H1299 cells by ChIP assays followed by high-throughput sequencing (ChIP-seq) (Fig. 6a ). p300/CBP has been previously reported to associate with both H3K27 hyperacetylated active enhancers and poised regulatory regions enriched in H3K27me3 [26] [27] [28] . ChIP-seq 60  80  10  20  40  60  80  10  20  40  60  80  10  20  40  60  80  10  20  40  60  80  10  20  40  60  80  10  20  40  60  80  10  20  40  60  80   10  20  40  60  80  10  20  40  60  80  10  20  40  60  80  10 using the M2 Flag antibody in the cells expressing Flag-tagged wild-type p300-BRPHZT identified 679 p300-BRPHZT binding sites in both regions. An evident increase in H3K18ac and H3K27ac occupancies, especially in the regions flanking H3K27 pre-acetylated sites, was also observed in these cells (Fig. 6a,b and Supplementary Table 1 ). In contrast to the wild-type protein, the two ZZ domain mutants, N1671A and D1690A, were incapable of gaining the chromatin binding, and no increase in H3K18ac and H3K27ac occupancies was observed in the cells expressing these mutants (Fig. 6a,b) . Furthermore, the loss-of-function mutations of the ZZ domain considerably decreased binding of p300-BRPHZT to individual genes and led to a notable reduction in the H3K18 and H3K27 acetylation levels on these genes ( Fig. 6c and Supplementary Fig. 7c) . Similarly, the N1132A mutation that abrogates acetyllysine binding activity of bromodomain resulted in a decrease in p300-BRPHZT occupancy and H3K18ac and H3K27ac levels at the target gene regions (Fig. 6d ). Together, these results underscore the critical roles of the ZZ/H3 and bromodomain/ acetyllysine interactions in p300 function in maintaining histone H3K18 and H3K27 acetylation in cells, corroborating the in vitro findings described above.
Discussion
In conclusion, we have identified a novel function for the ZZ domain of p300. It recognizes histone H3 tail through a unique and previously uncharacterized mechanism. The H3 binding activity of ZZ and the acetyllysine binding activity of bromodomain are both essential for the association of p300 with chromatin. We show that the acetyllysine binding of bromodomain is necessary for p300 to catalyze acetylation of virtually all lysine residues in H3 and H4 tested, whereas the ability of p300 to acetylate primarily H3K27 and H3K18 is due to the binding of the ZZ domain to the N terminus of H3. A model of the p300-BRPHZ/H3 complex generated using the simulated annealing method and the crystal structures of p300 BRPH 13 and H3/ZZ revealed a ~38-Å distance between the H3A1-binding site of ZZ and the catalytic site in the HAT domain ( Supplementary Fig. 7d ). This distance is too long for Lys9 or Lys14 of H3 to occupy the active site of the HAT domain and thus be acetylated in cis when the N terminus of H3 is locked through the interaction with ZZ; however, other lysine residues (K18, K23, K27) in the H3 tail can reach the active site. Furthermore, the substratebinding groove of the HAT domain is highly negatively charged and would favor the positively charged H3 tail. Collectively, these results (duplicate measurements) . b, Binding curves used to determine the K d values by fluorescence. c, Western blot analysis of histone acetylation levels in whole-cell extract of H1299 cells stably expressing wild-type FLAG-p300 BRPHZT or the indicated mutants. d, Quantification of the indicated histone acetylation levels from three biological replicates as in c. Total H3 or H4 was used for normalization. e, Western blot analysis of histone acetylation levels in whole-cell extract of H1299 cells stably expressing the indicated FLAG-p300 BRPHZT fragments. f, Quantification of the indicated histone acetylation levels from three biological replicates as in e. Total H3 or H4 was used for normalization. Error bars in panels d and f represent s.e.m. from three independent batches of stable cells (n = 3 biological replicates). Uncropped blot images (c and e) are shown in Supplementary Data Set 1. 
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Target loci Neg. Ctrl. Fig. 6 | ZZ is required for binding of p300 to chromatin and its acetylation activity on H3K18 and H3K27 in cells. a, Heatmap of normalized H3K27ac (purple), H3K4me1 (green), H3K27me3 (scarlet), FLAG (brown), and H3K18ac (blue) ChIP-seq signals centered on FLAG binding sites in a ± 20-kb window in H1299 control cells and H1299 cells stably expressing wild-type FLAG-p300 BRPHZT or the indicated ZZ mutants. The color keys represent signal density. The peaks are divided into two groups (H3K27 acetylated or H3K27 methylated) based on the pre-existing H3K27 modifications at the peak center. b, Box plots compare FLAG, H3K18ac, and H3K27ac occupancies in different samples at FLAG binding peaks. All FLAG peaks are divided into two groups as in a. The center line of the box represents the median and box limits indicate the 25th and 75th percentiles. Two-tailed paired Student's t-test was used for statistical analyses. c, qPCR analysis of the FLAG-p300 BRPHZT , H3K18ac, and H3K27ac ChIP at target loci (locations indicated by black line in Supplementary Fig. 7c ) and two negative control loci in H1299 cells stably expressing wild-type FLAG-p300 BRPHZT or the indicated mutants. IgG or H3 ChIP was used for normalization. d, qPCR analysis of the FLAG-p300 BRPHZT , H3K18ac, and H3K27ac ChIP at target loci and two negative control loci in H1299 cells stably expressing wild-type FLAG-p300 BRPHZT or the N1132A bromodomain mutant. IgG or H3 ChIP was used for normalization. Error bars in c and d represent s.e.m. from three individual experiments (n = 3 experimental repeats). *P < 0.05; **P < 0.01 by two-tailed unpaired t-test. Neg. Ctrl., negative control; NS, not significant.
suggest that binding of p300-ZZ to the N terminus of H3 provides selectivity of the HAT domain toward the distal lysine sites in H3, such as H3K18 and H3K27. Intriguingly, we found that homologous CBP-ZZ binds to H3 weakly ( Supplementary Fig. 8) , and it will be interesting in future studies to differentiate the biological roles of p300 and CBP that are due to different activities of their ZZ domains.
Methods
Methods, including statements of data availability and any associated accession codes and references, are available at https://doi. org/10.1038/s41594-018-0114-9.
Materials. The coding DNA sequences encoding human full-length p300 protein and the p300 BRPHZT region (amino acids 1,035-1,830) were cloned into pENTR3C vector and subsequently cloned into p3FLAG and pCDH-FLAG destination vectors using Gateway techniques (Invitrogen), respectively. The coding DNA sequences encoding the human p300 bromodomain-RING-PHD-HAT-ZZ region (BRPHZ, amino acids 1,035-1,720) and ZZ domain (amino acids 1,650-1,720) were cloned into the pGEX-6P-1 vector (GE Healthcare). Point mutations and deletions were generated using a site-directed mutagenesis kit (Stratagene) and verified by Sanger sequencing. Histone peptides bearing different modifications were synthesized at CPC, LLC. Anti-histone antibodies including anti-H3 (Ab1791), anti-H3K4ac (ab176799), anti-H3K9ac (Ab32129), anti-H3K27ac (Ab4729), and anti-H4 (Ab7311) were obtained from Abcam. Anti-H3K9ac (61251) and anti-H3K18ac (39755) antibodies were from Active Motif. Anti-acetyl-Histone H4 antibody (06-598) was from Millipore. Anti-GST (sc-459) antibody was from Santa Cruz. Anti-FLAG (M2, F1804) antibody was from Sigma. Fluorescent secondary antibodies (926-32211 and 926-68020) were from LI-COR. Mononucleosomes reconstituted from recombinant histones (16-0009) were from EpiCypher.
Protein expression and purification for pull-down assays. p300-BRPHZ and p300-ZZ cloned in the pGEX-6P-1 vector were expressed in BL21 Rosetta 2 cells. Protein production was induced with 0.2 mM isopropyl-β -d-thiogalactoside and cultured overnight at 16 °C in Luria broth medium supplemented with 0.05 mM ZnCl 2 . The GST-tagged proteins were purified on glutathione Sepharose 4B beads (Amersham) in binding buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.05% NP-40, 1 mM phenylmethyl sulfonyl fluoride, plus protease inhibitors (Roche)) and eluted by 100 mM Tris pH 8.0 containing 15 mg ml −1 reduced glutathione (Sigma). All proteins harboring mutations or deletions were expressed and purified as wildtype proteins.
Peptide pull-down assays. Peptide pull-down assays were performed as described previously 29 . In brief, 1 μ g biotinylated histone peptides with different modifications were incubated with 1-2 μ g GST-fused p300 ZZ domain in binding buffer (50 mM Tris-HCl pH 7.5, 300 mM NaCl, 0.1% NP-40, 1 mM phenylmethyl sulfonyl fluoride) overnight with rotation at 4 °C. Streptavidin beads (Amersham) were added to the mixture, and the mixture was incubated for 1 h with rotation at 4 °C. The beads were then washed three times and the bound proteins were analyzed using SDS-PAGE and western blotting.
Calf thymus histone pull-down assay. Full-length histone pull-down assays were performed as described previously 30 . Briefly, 2 µ g GST-tagged protein was incubated with 10 µ g calf thymus total histones (Worthington) in binding buffer (50 mM Tris-HCl pH 7.5, 1 M NaCl, 1% NP-40) at 4 °C overnight with rotation. Glutathione Sepharose 4B beads (Amersham) were added to the solution and incubated for 1 h. The beads were then washed six times and bound histones were detected using SDS-PAGE and western blotting.
Salt fractionation. Salt fractionation of nuclei was performed as previously described 31 . In short, cells were swollen with hypotonic buffer (10 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl) and lysed by gentle disruption to isolate nuclei. The nuclei were incubated with wash buffer (20 mM HEPES pH 7.9, 1.5 mM MgCl 2 , 0.2 mM EDTA, 25% glycerol) containing 75 mM NaCl for 30 min at 4 °C and then pelleted and the supernatant fraction was collected. The nuclei were then similarly washed by wash buffer containing 150 mM, 300 mM, and 600 mM NaCl and the supernatant fraction of each step was collected. After the final wash step, the pellet was resuspended and sonicated before collection. The His-tag proteins were purified on Ni-NTA beads (Qiagen) in 20 mM Tris-HCl (pH 7.5) buffer, supplemented with 300 mM NaCl and 10 mM ßME. The His-tag was cleaved overnight at 4 °C with PreScission or Ulp1 protease. The GST-tagged proteins were purified on glutathione Sepharose 4B beads (GE Healthcare) in 20 mM Tris-HCl (pH 7.0) buffer, supplemented with 100 mM NaCl and 5 mM dithiothreitol. The GST tag was cleaved overnight at 4 °C with Thrombin protease. The GST-tagged p300-BRPHZ and mutants were purified as above and cleaved overnight at 4 °C with PreScission. Unlabeled proteins were further purified by size exclusion chromatography and concentrated in Millipore concentrators.
Protein expression and purification
All mutants were generated by site-directed mutagenesis using the Stratagene QuickChange mutagenesis protocol, and grown and purified as wild-type proteins.
NMR experiments.
NMR experiments were carried out at 298 K on Varian INOVA 600 MHz and 900 MHz spectrometers. NMR samples contained 0.1 mM uniformly 15 N-labeled wild-type or mutated p300-ZZ, p300-HAT-ZZ, p300-bromodomain-RING-PHD, and CBP-ZZ proteins in 20 mM Tris-HCl (pH 7.0) buffer supplemented with 100 mM NaCl, 5 mM dithiothreitol, and 8% D 2 O. Binding was characterized by monitoring chemical shift changes in the proteins induced by histone peptides (synthesized by SynPeptide).
X-ray crystallography. The p300 H3-linked ZZ domain (amino acids 1,663-1,713) was crystallized. For crystallization, the purified H3-ZZ (15 mg ml −1 ) was buffer exchanged into 5 mM HEPES (pH 7.4), 50 mM NaCl, and 0.5 mM TCEP before crystallization. Good quality diffracting crystals were obtained at 4 °C in 0.1 M HEPES and 70% MPD (pH 7.5). Data collection was performed at the ALS 4.2.2 beamline, Berkeley. HKL3000 was used for indexing, scaling, and data reduction. Solution was found by the single-wavelength anomalous dispersion method with Zn anomalous signal. Manual model building was performed using Coot 32 and the structure was refined using Phoenix Refine 33 . The final structure was verified by MOLProbity 34 showing 94.1% and 5.9% of residues in the most favored regions and additionally allowed regions, respectively. The X-ray diffraction and structure refinement statistics are summarized in Table 1 .
Fluorescence spectroscopy. Spectra were recorded at 25 °C on a Fluoromax-3 spectrofluorometer (HORIBA) as described previously 35 The K d values were averaged over three or two separate experiments as stated in corresponding figure legends, with error calculated as the standard deviation between the runs.
Modeling of the H3-bound BRPHZ region of p300. The model of the complex of p300 BRDHZ (amino acids 1,047-1,713) with H3 tail (1-31) was generated using the crystal structure of BRDH (Protein Data Bank (PDB) 4BHW) 13 and the H3-ZZ complex and the simulated annealing method in Xplor-NIH 36 . The lysine portion of the bi-substrate Lys-CoA was modified into the side chain of Lys27 of H3, and then the H3/ZZ complex was modeled onto the crystal structure with a flexible linker (residues 1,661-1,664). The model of the complex was treated as an initial structure and refined by simulated annealing. During the refinement, the backbone atoms of BRDH region (amino acids 1,047-1,660) were fixed, whereas the backbone atoms of the H3(amino acids 1-4)/ZZ(amino acids 1,665-1,713) complex were grouped and allowed to move as a rigid body. Distances between the Lys-CoA and residues W1436 and S1396 in the crystal structure were used as additional restraints to maintain the active site conformation. At all times, residues 1,661-1,664 of p300 and residues 5-31 of H3 were set to be fully flexible. Twenty models were calculated and six structures with the lowest energy were selected for further analysis.
In vitro HAT assays. For HAT assays on recombinant nucleosomes containing full-length histone H3.1, purified wild-type or mutated p300 BRPHZ (300 nM) was incubated with recombinant mononucleosome (100 nM) in HAT reaction buffer (50 mM Tris pH 8.0, 0.1 mM EDTA, 10% glycerol, 1 mM phenylmethyl sulfonyl fluoride, and 1 mM dithiothreitol) in a total volume of 50 µ l. After prewarming at 37 °C for 5 min, reactions were initiated with the addition of acetyl-CoA (Sigma) to
